Ursprung des Netzwerks ersten Grades von Irene Chong
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Cambridge Science Corp.
 Cambridge Science Corp. BiotechnologyHealth Technology Cambridge Science Corp. engages in investing in the medicine. It also engages in improving patient lives through the acceleration of translational research and develops internal drug development programs. The firm finances and manages biotech companies commercializing novel technologies developed in the labs and the research institutions. The company was founded in 2017 and is headquartered in Cambridge, MA.
3
| Private Company | Biotechnology | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Irene Chong
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
| PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Director of Finance/CFO | |
| HVIVO PLC | Miscellaneous Commercial Services | Director/Board Member | |
| SOLE REALISATION COMPANY PLC | Investment Managers | Director/Board Member | |
| Syracuse University | College/University | Masters Business Admin | |
Whirlpool Financial Corp.
 Whirlpool Financial Corp. Investment ManagersFinance Part of Whirlpool Corp., Whirlpool Financial Corp. provides financial advisory services. | Investment Managers | Director of Finance/CFO | |
| NOVIMMUNE SA | Medical/Nursing Services | Director of Finance/CFO | |
| U.B. Vehicle Leasing, Inc. | President | ||
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Internet Software/Services | Director/Board Member | |
| Hamlin Scientific Corp. | Director of Finance/CFO | ||
| Vivtex Corp. | Director/Board Member | ||
KYTTARO Ltd.
 KYTTARO Ltd. BiotechnologyHealth Technology Kyttaro Ltd. develops monoclonal antibodies for potential treatment of atherosclerotic cardiovascular diseases. The company is based in Oxford, UK. The British company was founded in 2021. The CEO is Douglas Eby. | Biotechnology | Chief Executive Officer |
Statistik
International
| Vereinigte Staaten | 10 |
| Vereinigtes Königreich | 5 |
| Schweiz | 2 |
| Japan | 2 |
Sektoral
| Finance | 5 |
| Health Technology | 3 |
| Health Services | 3 |
| Commercial Services | 3 |
| Consumer Services | 2 |
Operativ
| Director/Board Member | 9 |
| Director of Finance/CFO | 8 |
| Chief Executive Officer | 3 |
| President | 2 |
| Independent Dir/Board Member | 2 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Francis Winschel | 14 |
| Douglas Eby | 2 |
| Gary Steinberg | 2 |
- Börse
- Insiders
- Irene Chong
- Unternehmensverbindungen
